Scientists create tailored drug for aggressive breast cancer
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
38 minutes ago
0
0
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
38 minutes ago
0
0
Researchers at the University of Cincinnati College of Medicine have created a scoring model that uses key health indicators to accurately predict recovery for patients who experience kidney failure due to acute kidney injury ...
12 hours ago
0
1
Researchers from Children's Hospital of Philadelphia (CHOP), the Perelman School of Medicine at the University of Pennsylvania, and the National Cancer Institute (NCI) of the National Institutes of Health have developed a ...
12 hours ago
0
8
Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers at Oregon Health & Science University have developed a first-of-its-kind drug that inhibits ...
14 hours ago
0
28
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, ...
15 hours ago
0
0
A middle-aged American man with no previous medical history was found unconscious in his hotel room, with "unidentified crushed pills and a white residue" on a nearby table, according to a recent paper in BMJ Case Reports. ...
15 hours ago
0
17
Definitions of long COVID and care models are evolving, but considerable variability is seen in these models, according to a review published online May 21 in the Annals of Internal Medicine.
18 hours ago
0
0
Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.
May 20, 2024
0
22
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug—dupilumab—that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers ...
May 20, 2024
0
17
As research continues to produce evidence about the underlying causes of obesity and optimal strategies to treat and manage obesity have evolved, there are disparities in application of the latest scientific advances in the ...
May 20, 2024
0
8